Evidence map›Paper›PMID 40495906›Full record

ArticleCurrent therapeutic research, clinical and experimental2025

A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population.

Jad Chidiac, Reine-Marie Kahwaji, Souheil Hallit, Yara Yazbeck, Bassem Akiki, Charbel Yazbeck

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current therapeutic research, clinical and experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jad ChidiacSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Reine-Marie KahwajiSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Souheil HallitSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Yara YazbeckSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Bassem AkikiSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Charbel YazbeckSchool of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Concomitant therapy and bismuth quadruple therapy are both recommended as first-line treatment regimens for the empiric treatment of Objective: Our goal was to compare both treatment regimens among a sample of the Lebanese population to eventually conclude whether one of these therapies has a higher efficacy than the other one as a first- and second-line treatment regimens. Methods: It is a randomized, prospective, and crossover study, started from March 2016 to December 2018. Participants were randomly chosen patients diagnosed with active Results: Both regimens demonstrated similar efficacy as first-line therapies for Conclusions: Bismuth quadruple therapy and concomitant therapy are both equally effective first-line treatment regimens for the eradication of

Indexed as

Bismuth quadruple therapyConcomitant therapyEradicationFirst-line therapy regimenHelicobacter pyloriSecond-line therapy regimen

Identifiers

PMID40495906
PMCPMC12151695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.